Arrowstreet Capital
IMI

Arrowstreet Capital’s Intermolecular, Inc. IMI Stock Holding History

Arrowstreet Capital’s Portfolio IMI Stock Details IMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-59,382
Closed -$138K – 1189
2014
Q2 		$138K Buy
+59,382
New +$148K ﹤0.01% 933

Other funds holding IMI

RCM
Raging Capital Management Rocky Hill, New Jersey $18.2M AUM 17.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
ERSOT
Employees Retirement System of Texas Austin, Texas $12.6B AUM 31.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SPM
Symmetry Peak Management Radnor, Pennsylvania $369M AUM 148.4% 1-Year Est. Return
BA
BlackRock Advisors Wilmington, Delaware $98.8B AUM 15.8% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return

Arrowstreet Capital's IMI Position: Q3 2014 in Review

Arrowstreet Capital sold out of Intermolecular, Inc. (IMI) in Q3 2014, closing a stake of 59,382 shares — an estimated $138K sold.

Arrowstreet Capital first reported a position in IMI in Q2 2014 and held it in 1 quarter. The position peaked at $138K in Q2 2014. 33 funds tracked by Wall St. Rank hold IMI as of Q3 2014.

  • Arrowstreet Capital reported no remaining Intermolecular, Inc. position as of Q3 2014 after selling out during the quarter.
  • Arrowstreet Capital sold 59,382 Intermolecular, Inc. shares in Q3 2014, an estimated $138K.
  • Arrowstreet Capital first reported a position in Intermolecular, Inc. in Q2 2014 and held it in 1 quarter.
  • Arrowstreet Capital's Intermolecular, Inc. position peaked at $138K in Q2 2014.
  • 33 funds tracked by Wall St. Rank held Intermolecular, Inc. as of Q3 2014.

Based on Arrowstreet Capital's 13F filing for Q3 2014, filed 14 Nov 2014.